In 2015, VCP/p97 overexpression was detected in breast cancer tissues compared to normal tissues using immunohistochemistry and correlated with decreased overall survival rates of these patients, which highlighted VCP/p97 as a useful prognostic biomarker in breast carcinoma [78]. This evidence concerns the gene VCP and breast cancer.